KRISTIN STEVENS

Defense Appropriations for Cyber and Mission Assurance, 8(a) Native Hawaiian Organization Policy, Rare earth mine and AUKUS

FY27 Defense Appropriations for munitions demilitarization, Defense Production Act, white phosphorus and chembio demilitarization; Domestic Chemical production

NDAA and Defense Appropriations for Cyber-Security and small business 8(A) Program

Pandemic and All Hazard Preparedness Act, FY27 LHHS and Defense Appropriations for next generation blood products; FY27 NDAA, FY27 LHHS and FY27 DoD Authorization and Appropriations for Freeze-dried platelet and next gen blood products

National Guard Funding and Defense Appropriations; FY27 NDAA and FY27 Appropriations Air Force O&M

Compression and Damage Control Resuscitation

Labor/HHS Appropriation - Warm Base and Flexible Contracting, SNS and BARDA Funding, OTC Test Coverage, PAHPA. Industrial Base Management & Supply Chain (IBMSC) Funding; FY26 Defense Appropriations for DHA funding and VA funding for laboratory equipment.

Policies, federal programs, and procurement related to access to affordable medicines and pharmaceutical supply chain.

Testosterone replacement therapy; FY28 Defense Authorization and Appropriations.

Rare Disease Policy and FDA Policy

Provide strategic government affairs counsel and legislative consulting services regarding defense authorization, appropriations, counter-UAS, and artificial intelligence (AI) matters.

Testosterone replacement therapy; FY28 Defense Authorization and Appropriations.

Testosterone replacement therapy; FY28 Defense Authorization and Appropriations.

LHHS Appropriation R&D Funding, Pandemic Preparedness Funding for Next Generation Products; FY27 Defense Appropriation for broad-spectrum antivirals, FY27 FDA-AG for cocaine overdose funding; Alternative to Pain Act and Chronic Pain coverage

Defense Health Agency for Enterprise-wide Revenue Cycle Management, FY27 NDAA and FY27 Defense Appropriation for RCM

FY27 Appropriations and policy for the Strategic National Stockpile, BARDA, and Industrial Base Management Supply Chain, Pandemic and All Hazards Preparedness Act (PAHPA), PASTEUR Act and MCM Development funding; AMR issues; PBS/SRF, and PRV and MCM voucher programs.

FY27 Defense funding for nuclear security and FY27 NDAA

Defense Appropriations for Cyber and Mission Assurance, 8(a) Native Hawaiian Organization Policy, Rare earth mine and AUKUS

FY26 and FY27 Defense Appropriations for munitions demilitarization, Defense Production Act, white phos and chembio demilitarization; Domestic Chemical production

NDAA and Defense Appropriations for Cyber-Security and small business 8(A) Program

Pandemic and All Hazard Preparedness Act, FY27 LHHS and Defense Appropriations for next generation blood products; FY27 NDAA, FY27 LHHS and FY27 DoD Authorization and Appropriations for Freeze-dried platelet and next gen blood products

National Guard Funding and Defense Appropriations; FY27 NDAA and FY27 Appropriations Air Force O&M

Labor/HHS Appropriation - Warm Base and Flexible Contracting, SNS and BARDA Funding, OTC Test Coverage, PAHPA. Industrial Base Management & Supply Chain (IBMSC) Funding; FY26 Defense Appropriations for DHA funding and VA funding for laboratory equipment.

Policies, federal programs, and procurement related to access to affordable medicines and pharmaceutical supply chain.

Rare Disease Policy and FDA Policy

Provide strategic government affairs counsel and legislative consulting services regarding defense authorization, appropriations, counter-UAS, and artificial intelligence (AI) matters.

Provide strategic government affairs counsel and legislative consulting services regarding defense authorization, appropriations, counter-UAS, and artificial intelligence (AI) matters.

Policies, federal programs, and procurement related to access to affordable medicines and pharmaceutical supply chain.

LHHS Appropriation R&D Funding, Pandemic Preparedness Funding for Next Generation Products; FY27 Defense Appropriation for broad-spectrum antivirals, FY27 FDA-AG for cocaine overdose funding; Alternative to Pain Act and Chronic Pain coverage

Defense Health Agency for Enterprise-wide Revenue Cycle Management, FY27 NDAA and FY27 Defense Appropriation for RCM

FY27 Appropriations and policy for the Strategic National Stockpile, BARDA, and Industrial Base Management Supply Chain, Pandemic and All Hazards Preparedness Act (PAHPA), PASTEUR Act and MCM Development funding; AMR issues; PBS/SRF, and PRV and MCM voucher programs.

FY27 Defense funding for nuclear security and FY27 NDAA

Defense Appropriations for Cyber and Mission Assurance, 8(a) Native Hawaiian Organization Policy, Rare earth mine and AUKUS

FY26 and FY27 Defense Appropriations for munitions demilitarization, Defense Production Act, white phos and chembio demilitarization; Domestic Chemical production

NDAA and Defense Appropriations for Cyber-Security and small business 8(A) Program

Pandemic and All Hazard Preparedness Act, FY27 LHHS and Defense Appropriations for next generation blood products; FY27 NDAA, FY27 LHHS and FY27 DoD Authorization and Appropriations for Freeze-dried platelet and next gen blood products

National Guard Funding and Defense Appropriations; FY27 NDAA and FY27 Appropriations Air Force O&M

Labor/HHS Appropriation - Warm Base and Flexible Contracting, SNS and BARDA Funding, OTC Test Coverage, PAHPA. Industrial Base Management & Supply Chain (IBMSC) Funding; FY26 Defense Appropriations for DHA funding and VA funding for laboratory equipment

Rare Disease Policy and FDA Policy

Defense funding and FY27 NDAA

LHHS Appropriation R&D Funding, Pandemic Preparedness Funding for Next Generation Products; FY26 Defense Appropriation for broad-spectrum antivirals, FY26 LHHS for Long COVID and cocaine overdose funding; Alternative to Pain Act and Chronic Pain coverage

Health, FDA issues related to Hypoxic Ischemic Encephalopathy "HIE."

Defense Health Authorization for Enterprise-wide Revenue Cycle Management, FY26 NDAA, Defense Appropriation

FY26 Appropriations and policy for the Strategic National Stockpile, BARDA, and Industrial Base Management Supply Chain, Pandemic and All Hazards Preparedness Act (PAHPA), PASTEUR Act and MCM Development funding; AMR issues.

Defense Appropriations for Cyber and Mission Assurance, 8(a) Native Hawaiian Organization Policy, Rare earth mining and AUKUS

FY26 Defense Appropriations for munitions demilitarization, Defense Production Act and chembio demilitarization; Domestic Chemical production

NDAA and Defense Appropriations for Cyber-Security and small business 8(A) Program

Generate advocacy for the expansion of domestic infant formula manufacturing; House and Senate Appropriations; FY26 AG Appropriations for infant formula manufacturing, and tax credit for domestic infant formula manufacturing; FDA and Domestic Infant Formula Manufacturing and Tax Credits

Availability of domestic supply chain materials, mother and baby nutrition; FY26 Appropriations and funding for mother and baby nutrition; FY26 AG Appropriations for infant formula manufacturing, and tax credit for domestic infant formula manufacturing; FDA and Domestic Infant Formula Manufacturing and Tax Credits

Pandemic and All Hazard Preparedness Act, FY26 LHHS and Defense Appropriations for next generation blood products; FY26 NDAA, FY26 LHHS and FY26 DoD Authorization and Appropriations for Freeze-dried platelet and next gen blood products

National Guard Funding and Defense Appropriations; FY26 Air Force O&M Funding

Labor/HHS Appropriation - Warm Base and Flexible Contracting, SNS and BARDA Funding, OTC Test Coverage, PAHPA. Industrial Base Management & Supply Chain (IBMSC) Funding; FY26 Defense Appropriations for DHA funding and VA funding for laboratory equipment

Rare Disease Policy and FDA Policy

Rare Disease Policy and FDA Policy

LHHS Appropriation R&D Funding, Pandemic Preparedness Funding for Next Generation Products; FY26 Defense Appropriation for broad-spectrum antivirals, FY26 LHHS for Long COVID and cocaine overdose funding; Alternative to Pain Act and Chronic Pain coverage

Health, FDA issues related to Hypoxic Ischemic Encephalopathy "HIE."

Defense Health Authorization for Revenue Cycle Management, FY26 NDAA

FY26 Appropriations and policy for the Strategic National Stockpile, BARDA, and Industrial Base Management Supply Chain, Pandemic and All Hazards Preparedness Act (PAHPA), PASTEUR Act and MCM Development funding; AMR issues.

Defense Appropriations for Cyber and Mission Assurance, 8(a) Native Hawaiian Organization Policy, Rare earth mining and AUKUS

FY26 Defense Appropriations for munitions demilitarization, Defense Production Act and chembio demilitarization; Domestic Chemical production

NDAA and Defense Appropriations for Cyber-Security and small business 8(A) Program

Generate advocacy for the expansion of domestic infant formula manufacturing; House and Senate Appropriations; FY26 AG Appropriations for infant formula manufacturing, and tax credit for domestic infant formula manufacturing; FDA and Domestic Infant Formula Manufacturing and Tax Credits

Availability of domestic supply chain materials, mother and baby nutrition; FY26 Appropriations and funding for mother and baby nutrition; FY26 AG Appropriations for infant formula manufacturing, and tax credit for domestic infant formula manufacturing; FDA and Domestic Infant Formula Manufacturing and Tax Credits

Pandemic and All Hazard Preparedness Act, FY26 LHHS and Defense Appropriations for next generation blood products; FY26 NDAA, FY26 LHHS and FY26 DoD Authorization and Appropriations for Freeze-dried platelet and next gen blood products

National Guard Funding and Defense Appropriations; FY26 Air Force O&M Funding

Labor/HHS Appropriation - Warm Base and Flexible Contracting, SNS and BARDA Funding, OTC Test Coverage, PAHPA. Industrial Base Management & Supply Chain (IBMSC) Funding; FY26 Defense Appropriations for DHA funding and VA funding for laboratory equipment

Generate advocacy for the expansion of domestic infant formula manufacturing; House and Senate Appropriations; FY26 AG Appropriations for infant formula manufacturing, and tax credit for domestic infant formula manufacturing; FDA and Domestic Infant Formula Manufacturing and Tax Credits;

Availability of domestic supply chain materials, mother and baby nutrition; FY26 Appropriations and funding for mother and baby nutrition; FY26 AG Appropriations for infant formula manufacturing, and tax credit for domestic infant formula manufacturing; FDA and Domestic Infant Formula Manufacturing and Tax Credits

LHHS Appropriation R&D Funding, Pandemic Preparedness Funding for Next Generation Products; FY26 Defense Appropriation for broad-spectrum antivirals, FY26 LHHS for Long COVID and cocaine overdose funding; Alternative to Pain Act and Chronic Pain coverage

Health, FDA issues related to Hypoxic Ischemic Encephalopathy "HIE."

Defense Health Authorization for Revenue Cycle Management, FY26 NDAA;

FY26 Appropriations and policy for the Strategic National Stockpile, BARDA, and Industrial Base Management Supply Chain, Pandemic and All Hazards Preparedness Act (PAHPA), PASTEUR Act and MCM Development funding; AMR issues.

Defense Appropriations for Cyber and Mission Assurance, 8(a) Native Hawaiian Organization Policy, Rare earth mining.

FY26 Defense Appropriations for munitions demilitarization, Defense Production Act and chembio demilitarization; Domestic Chemical production

NDAA and Defense Appropriations for Cyber-Security and small business 8(A) Program

Generate advocacy for the expansion of domestic infant formula manufacturing; House and Senate Appropriations; FY26 AG Appropriations for infant formula manufacturing, and tax credit for domestic infant formula manufacturing; FDA and Domestic Infant Formula Manufacturing and Tax Credits;

Generate advocacy for the expansion of domestic infant formula manufacturing; House and Senate Appropriations; FY26 AG Appropriations for infant formula manufacturing, and tax credit for domestic infant formula manufacturing; FDA and Domestic Infant Formula Manufacturing and Tax Credits;

Pandemic and All Hazard Preparedness Act, FY26 LHHS and Defense Appropriations for next generation blood products; FY26 NDAA, FY26 LHHS and FY26 DoD Authorization and Appropriations for Freeze-dried platelet and next gen blood products

National Guard Funding and Defense Appropriations; FY26 Air Force O&M Funding

Labor/HHS Appropriation - SNS Funding and DoD Appropriation - OTC Test Coverage, PAHPA. Industrial Base Management & Supply Chain (IBMSC) Funding; FY26 Defense Appropriations for DHA funding

Defense Health Authorization for Revenue Cycle Management, FY26 NDAA;

Health, FDA issues related to Hypoxic Ischemic Encephalopathy "HIE."

FY26 Appropriations and policy for the Strategic National Stockpile, BARDA, and Industrial Base Management Supply Chain, Pandemic and All Hazards Preparedness Act (PAHPA), PASTEUR Act and MCM Development funding; AMR issues.

LHHS Appropriation R&D Funding, Pandemic Preparedness Funding for Next Generation Products; FY26 Defense Appropriation for broad-spectrum antivirals, FY26 LHHS for Long COVID and cocaine overdose funding; Alternative to Pain Act and Chronic Pain coverage

Labor/HHS Appropriation - SNS Funding and DoD Appropriation - OTC Test Coverage, PAHPA. Industrial Base Management & Supply Chain (IBMSC) Funding; FY26 Defense Appropriations for DHA funding

National Guard Funding and Defense Appropriations; FY26 Air Force O&M Funding

Generate advocacy for the expansion of domestic infant formula manufacturing; House and Senate Appropriations; FY26 AG Appropriations for infant formula manufacturing, and tax credit for domestic infant formula manufacturing; FDA and Domestic Infant Formula Manufacturing and Tax Credits;

Availability of domestic supply chain materials, mother and baby nutrition; FY26 Appropriations and funding for mother and baby nutrition; FY26 AG Appropriations for infant formula manufacturing, and tax credit for domestic infant formula manufacturing; FDA and Domestic Infant Formula Manufacturing and Tax Credits

NDAA and Defense Appropriations for Cyber-Security and small business 8(A) Program

Pandemic and All Hazard Preparedness Act, FY26 LHHS and Defense Appropriations for next generation blood products; FY26 NDAA, FY26 LHHS and FY26 DoD Authorization and Appropriations for Freeze-dried platelet and next gen blood products

FY26 Defense Appropriations for munitions demilitarization, Defense Production Act and chembio demilitarization; Domestic Chemical production

FY25 Appropriations and policy for the Strategic National Stockpile, BARDA, and Industrial Base Management Supply Chain, Pandemic and All Hazards Preparedness Act (PAHPA), PASTEUR Act and MCM Development funding; AMR issues.

LHHS Appropriation R&D Funding, Pandemic Preparedness Funding for Next Generation Products; FY25 Defense Appropriation for broad-spectrum antivirals, FY25 LHHS for long covid and cocaine overdose funding

Defense Appropriation for Prosthetic Research for Infection Treatment and Prevention

Generate advocacy for the expansion of domestic infant formula manufacturing; House and Senate Appropriations; FY25 AG Appropriations for infant formula manufacturing, and tax credit for domestic infant formula manufacturing

Availability of domestic supply chain materials, mother and baby nutrition; FY25 Appropriations and funding for mother and baby nutrition; FY25 AG Appropriations for infant formula manufacturing, and tax credit for domestic infant formula manufacturing

NDAA and Defense Appropriations for Cyber-Security and small business 8(A) Program

Pandemic and All Hazard Preparedness Act, FY25 LHHS and Defense Appropriations for next generation blood products; FY25 NDAA, FY26 LHHS and FY 26 DoD Authorization and Appropriations for Freeze-dried platelet and next gen blood products;

FY25 Defense Appropriations for munitions demil, Defense Production Act and chembio demilitarization.

Defense appropriations for power generation and FY25 NDAA for power generation;

Defense appropriations for power generation and FY25 NDAA for power generation

FY25 Appropriations and policy for the Strategic National Stockpile, BARDA, and Industrial Base Management Supply Chain, Pandemic and All Hazards Preparedness Act (PAHPA), PASTEUR Act and MCM Development funding; AMR issues.

LHHS Appropriation R&D Funding, Pandemic Preparedness Funding for Next Generation Products; FY25 Defense Appropriation for broad-spectrum antivirals, FY25 LHHS for long covid and cocaine overdose funding